Skip to content

Development and Testing of a Pediatric Cervical Spine Injury Risk Assessment Tool

Development and Testing of a Pediatric Cervical Spine Injury Risk Assessment Tool

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05049330
Acronym
C-Spine
Enrollment
22444
Registered
2021-09-20
Start date
2018-12-12
Completion date
2023-07-01
Last updated
2026-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Spine Injury

Brief summary

Cervical spine injuries (CSI) are serious, but rare events in children. Spinal precautions (rigid cervical collar and immobilization on a longboard) in the prehospital setting may be beneficial for children with CSI, but are poorly studied. In contrast, spinal precautions for pediatric trauma patients without CSI are common and may be associated with harm. Spinal precautions result in well-documented adverse physical and physiological sequelae. Of substantial concern is that the mere presence of prehospital spinal precautions may lead to a cascade of events that results in the increased use of inappropriate radiographic testing in the emergency department (ED) to evaluate children for CSI and thus an unnecessary, increased exposure to ionizing radiation and lifetime risk of cancer. Most children who receive spinal precautions and/or are imaged for potential CSI, and particularly those imaged with computed tomography (CT), are exposed to potential harm with no demonstrable benefit. Therefore, there is an urgent need to develop a Pediatric CSI Risk Assessment Tool that can be used in the prehospital and ED settings to reduce the number of children who receive prehospital spinal precautions inappropriately and are imaged unnecessarily while identifying all children who are truly at risk for CSI.

Interventions

None listed

Sponsors

Julie Leonard
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Age 0-17 years * Known or suspected exposure to blunt trauma At least one of the following applies to the patient: * Undergoing trauma team evaluation * Transported from the scene to participating facility by EMS * Undergoing cervical spine imaging at participating facility * Transferred to participating facility with cervical spine imaging

Exclusion criteria

* Exposed to solely penetrating trauma (e.g. a gunshot or stab wound)

Design outcomes

Primary

MeasureTime frameDescription
Cervical Spine InjuryCSI diagnosed within 21 days of emergency department presentationThe primary outcome used to derive and validate the prediction rule is the presence of cervical spine injury (CSI) defined as vertebral fracture, ligamentous injury, intraspinal hemorrhage, or spinal cord injury involving the cervical region of the spine (occiput to the 7th cervical vertebra, including ligaments attaching the 7th vertebrae to the 1st thoracic vertebra) on any c-spine imaging modality, including x-ray, skeletal survey, CT scan, and/or MRI.

Countries

United States

Participant flow

Pre-assignment details

In the database, fourteen subjects were found to be duplicate enrollments.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
22430 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2618 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10145 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
111 Participants
Race (NIH/OMB)
Asian
220 Participants
Race (NIH/OMB)
Black or African American
4100 Participants
Race (NIH/OMB)
More than one race
411 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
99 Participants
Race (NIH/OMB)
Unknown or Not Reported
1726 Participants
Race (NIH/OMB)
White
10906 Participants
Region of Enrollment
United States
22430 Participants
Sex: Female, Male
Female
9362 Participants
Sex: Female, Male
Male
6855 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
60 / 11,85754 / 10,573
other
Total, other adverse events
0 / 11,8570 / 10,573
serious
Total, serious adverse events
0 / 11,8570 / 10,573

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 16, 2026